4D Molecular Therapeutics, Inc.
SEC Filing List
FDMT CIK: 0001650648
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | OLSHAN FROME WOLOSKY LLP /fa | 05/15/2026 | |||
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 05/13/2026 | ||
| SCHEDULE 13G | 05/12/2026 | ||||
| S-3 | Registration statement for specified tra... | 4d Molecular Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | 4d Molecular Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 8-K | Current report filing | 4d Molecular Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| ARS | Annual report to security holders | 4d Molecular Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/28/2026 | |
| DEF 14A | Definitive proxy statements | 4d Molecular Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/28/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | 4d Molecular Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/28/2026 | |
| No record found. | |||||
| Load More | |||||
